Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Adenosine deaminase 2 deficiency (DADA2) is an autoinflammatory disease characterized by inflammatory vasculopathy, early strokes associated often with hypogammaglobulinemia. Pure red cell aplasia, thrombocytopenia, and neutropenia have been reported. The defect is due to biallelic loss of function of ADA2 gene, coding for a protein known to regulate the catabolism of extracellular adenosine. We therefore investigated immune phenotype and B- and T-cell responses in 14 DADA2 patients to address if ADA2 mutation affects B- and T-cell function. Here, we show a significant decrease in memory B cells, in particular class switch memory, and an expansion of CD21low B cells in DADA2 patients. In vitro stimulated B lymphocytes were able to secrete nonfunctional ADA2 protein, suggesting a cell intrinsic defect resulting in an impairment of B-cell proliferation and differentiation. Moreover, CD4+ and CD8+ T cells were diminished; however, the frequency of circulating T follicular helper cells was significantly increased but they had an impairment in IL-21 production possibly contributing to an impaired B cell help. Our findings suggest that ADA2 mutation could lead to a B-cell intrinsic defect but also to a defective Tfh cell function, which could contribute to the immunodeficient phenotype reported in DADA2 patients. © 2020 Wiley-VCH GmbH.

Citation

Francesca Schena, Federica Penco, Stefano Volpi, Claudia Pastorino, Roberta Caorsi, Francesca Kalli, Daniela Fenoglio, Annalisa Salis, Arinna Bertoni, Ignazia Prigione, Paola Bocca, Antonella Insalaco, Fabrizio De Benedetti, Francesca Antonini, Alice Grossi, Sara Signa, Gianluca Damonte, Isabella Ceccherini, Gilberto Filaci, Elisabetta Traggiai, Marco Gattorno. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients. European journal of immunology. 2021 Jan;51(1):206-219

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32707604

View Full Text